Friday, October 23, 2009

Biocell Center opens amniotic stem cell bank in Medford

By Mass High Tech staff

Video Gallery

MHT's Julie Donnelly: Life science startups finding investments

MHT's Marc Songini: RI plans launch of cord blood center

MHT's Marc Songini: Mass. bio firms prep for lifting of stem cell ban

Related News

Biogen shareholders: CEO pay 'inconsistent' with poor stock performance [November 20, 2009]

Second license deal with Amgen to bring ImmunoGen another $35M [November 20, 2009]

German biotech Caprotec opens Burlington subsidiary [November 19, 2009]

Genzyme halts kidney treatment development [November 19, 2009]

ACT seeks FDA OK for stem cell study to treat blindness [November 19, 2009]

Biocell Center, a European biotechnology firm, has opened the first U.S. headquarters in Medford for the amniotic stem cell preservation company. Joining the official opening on Thursday was Governor Deval Patrick; Susan Windham-Bannister, president and CEO of the Massachusetts Life Sciences Center; Robert Coughlin, president and CEO of MassBio; and Paolo Alli, chief of the Cabinet of Governor Formigoni in Italy’s Lombardia region.

The company preserves stem cells from amniotic fluid and will do so for families interested in paying for the liquid nitrogen preservation of the stem cells in Biocell Center’s cryo-bank.

“Biocell Center selected Massachusetts because of its high concentration of leading medical centers and research institutions,” said Biocell Center CEO Kate Torchilin in a statement.

The company noted plans to work with hospitals and scientists in Boston and other parts of the U.S. on amniotic stem cell clinical research.